• Palvella Therapeutics COO Kathleen Goin sold 4,302 common shares on June 17, 2026 at about $110.72 to $112.23.
• Sales followed option exercises for 4,302 shares at $7.14 to $9.08.
• Goin’s direct common stock holdings fell to zero.
• She reported 17,219 stock options remaining outstanding.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palvella Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-076460), on June 22, 2026, and is solely responsible for the information contained therein.